George Webb - Investigative Journalist(@RealGeorgeWebb1) 's Twitter Profile Photo

Bob Malone is telling you the 5th Gen virus vaccine warfare will be coming from his Billionaire buddies in Windber, PA. We have to respond with information to prepare.

account_circle
Dr Jiang Da D (He/Him)(@jiangdadr) 's Twitter Profile Photo

True winner in my book at is personalized , clinical trials, more innovation from China, and new targeted therapies going after targetable mutations such as PI3K, BRAF, LGR5. Very times!!

account_circle
Sharyl Attkisson 🕵️‍♂️💼🥋(@SharylAttkisson) 's Twitter Profile Photo

'Suddenly all these cancers are being reawakened because of the vaccine that has been like a blast of disablement to the immune system'
Yale Epidemiologist Dr. Harvey Risch on impact on .
Full interview at link:
anchor.fm/sharylattkisso…

account_circle
Elicio Therapeutics(@ElicioTx) 's Twitter Profile Photo

Our CSO, Dr. Pete DeMuth, is presenting an overview of our lymph node-targeted approach focused on our lead candidate, ELI-002, at the KI Annual Research Symposia on hosted by the Koch Institute at MIT on Friday, June 23. Learn more: bit.ly/3JhcJLn

Our CSO, Dr. Pete DeMuth, is presenting an overview of our lymph node-targeted approach focused on our lead candidate, ELI-002, at the KI Annual Research Symposia on #CancerVaccines hosted by the @kochinstitute on Friday, June 23. Learn more: bit.ly/3JhcJLn #KIsymposium
account_circle
Bernard A Fox(@BernardAFox) 's Twitter Profile Photo

’s is a watershed for & Vaccines /our Clinical Cancer Research commentary spells out R thoughts on Alena Gros paper/Builds on Jonathan Yewdell, Gregory Ehx & Drs. Perrault, Wu, Regev & Explains >50yrs of aacrjournals.org/clincancerres/…

#Cancer’s #DarkMatter is a watershed for #immunotherapy & #CancerVaccines /our @CCR_AACR commentary spells out R thoughts on @alena_grosvidal paper/Builds on Jonathan Yewdell, @EhxGregory & Drs. Perrault, Wu, Regev & Explains >50yrs of #Tumor #immunology aacrjournals.org/clincancerres/…
account_circle
Xpeer Medical Education(@Xpeer5) 's Twitter Profile Photo

As we celebrate World Ovarian Cancer Day today💚, it's important to remember that ovarian cancer is one of the most deadly cancers affecting women worldwide. We also want to honor ovarian cancer patients.

As we celebrate World Ovarian Cancer Day today💚, it's important to remember that ovarian cancer is one of the most deadly cancers affecting women worldwide. We also want to honor ovarian cancer patients.

#WorldOvarianCancerDay #CancerVaccines #HopeForACure #mRNAtechnology
account_circle
CNS Pharma(@cns_pharma) 's Twitter Profile Photo

We are developing anti-cancer drug candidates for the treatment of primary and metastatic brain and CNS cancers. bit.ly/3npZn3X

$CNSP

account_circle
Roy de Souza(@roydesouza) 's Twitter Profile Photo

A success for personalized - in glioblastoma (brain cancer). 5 year survival increased from 5% to 13%.

Dendritic Cells (DCs) are mixed with patient's cancer cells then injected. The DCs take up proteins from the cancer cells then teach body to fight them 1/2

account_circle
Immuno Series(@ImmunoOncConf) 's Twitter Profile Photo

Evaxion Biotech's personalised cancer vaccine, dubbed EVX-01, has been granted fast track designation by the U.S. FDA for a combination trial with MSD's Keytruda in Europe, the US, and Australia.

Read Here: hubs.la/Q01zBRJ-0

account_circle
Elicio Therapeutics(@ElicioTx) 's Twitter Profile Photo

Our Chief Scientific Officer, Dr. Peter DeMuth, is presenting at this year's STING & TLR-Targeting Therapies Summit. He will discuss the potential of TLR agonists to enhance the efficacy of . Learn more here: bit.ly/44A5cA0

Our Chief Scientific Officer, Dr. Peter DeMuth, is presenting at this year's STING & TLR-Targeting Therapies Summit. He will discuss the potential of TLR agonists to enhance the efficacy of #cancervaccines. Learn more here: bit.ly/44A5cA0
account_circle
Journal of Functional Biomaterials(@JFB_MDPI) 's Twitter Profile Photo

📢Utilization of Stimuli-Responsive Biomaterials in the Formulation of Cancer Vaccines

In the development of , capable of generating strong cellular immune responses specific to antigens have shown tremendous promise

📌mdpi.com/2079-4983/14/5…

📢Utilization of Stimuli-Responsive Biomaterials in the Formulation of Cancer Vaccines

In the development of #cancervaccines, #biomaterials capable of generating strong cellular immune responses specific to antigens have shown tremendous promise

📌mdpi.com/2079-4983/14/5…
account_circle
Xenetic Biosciences(@XeneticBio) 's Twitter Profile Photo

Xenetic Biosciences is a biopharmaceutical company focused on advancing proprietary technology platforms across multiple high-value cancer indications. Learn more about us here: bit.ly/3xixJIx

$XBIO

account_circle
Chief Nerd(@TheChiefNerd) 's Twitter Profile Photo

NEW — Pfizer CEO Albert Bourla Announces Acquisition of Cancer Treatment Biotech Seagen For $43 Billion

“1-in-3 people in the world are going to have cancer in their lifetime…This is something like the mRNA for vaccines, [but] this is for cancer.”

account_circle
CancerVaccines(@ic2_vs) 's Twitter Profile Photo

📢 An exciting result of a collaboration with the lab of Alexey I. Nesvizhskii at the University of Michigan Medical School where had a unique opportunity to intern. Congrats to all authors! 👏➡️nature.com/articles/s4146… FNP Foundation for Polish Science Uniwersytet Gdański

account_circle
Queen's University Belfast 🎓(@QUBelfast) 's Twitter Profile Photo

We have just announced our 100th spin-out company.

AilseVax will develop cancer vaccine therapies that help teach the immune system about what cells “look like” so that it recognises and destroys them using the body’s own defences.

The Patrick G Johnston Centre for Cancer Research Qubis Trinity Innovation

account_circle